POLB — Poolbeg Pharma Balance Sheet
0.000.00%
Last trade - 00:00- £18.00m
- £10.18m
Annual balance sheet for Poolbeg Pharma, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Cash and Equivalents | ||||
| Cash and Short Term Investments | 20.9 | 16.2 | 12.2 | 7.82 |
| Net Total Receivables | 0.057 | 0.084 | 0.658 | 0.274 |
| Prepaid Expenses | ||||
| Total Current Assets | 21.5 | 17.2 | 13.5 | 8.56 |
| Net Intangible Assets | ||||
| Total Assets | 23 | 19.3 | 15.4 | 10.2 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 0.438 | 0.966 | 0.986 | 0.974 |
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Liabilities | 0.438 | 0.966 | 0.986 | 0.974 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Total Equity | 22.6 | 18.3 | 14.4 | 9.27 |
| Total Liabilities & Shareholders' Equity | 23 | 19.3 | 15.4 | 10.2 |
| Total Common Shares Outstanding |